Invivyd Inc.

Invivyd Inc. (IVVD) is a United States-based biotechnology company listed on the NASDAQ exchange, focused on discovering, developing, and commercializing antibody-based therapies. The company is dedicated to addressing serious viral diseases, particularly those where existing treatment options are limited or inadequate. Invivyd leverages its expertise in antibody engineering and development to create novel therapeutic candidates designed to neutralize and combat viral infections. Their research and development efforts are geared towards improving patient outcomes and providing innovative solutions in the field of infectious diseases. As a publicly traded company, Invivyd seeks to deliver value to its shareholders through the successful development and commercialization of its therapeutic pipeline.